Environmental, Health and Safety Lead
About the job
- A bachelor's degree in Chemical Engineering, Process Engineering, or a closely related engineering or scientific discipline is required.
- Relevant experience in pharmaceutical, biotechnology, chemical processing, or another regulated, technically complex manufacturing environment is required.
- Practical understanding of chemical and process hazards, risk assessment, and the hierarchy of controls is required.
- Experience supporting manufacturing operations, process changes, capital projects, equipment introduction, or technology transfer is required.
- Demonstrated ability to lead people or coordinate technical teams, manage competing priorities, and influence cross-functional stakeholders is required.
- Experience in incident investigation, audit or inspection readiness, corrective-action management, and technical report writing is required.
- Strong analytical judgment, communication, project-management, and problem-solving skills are required.
- Provide technical and operational EHS guidance to manufacturing, engineering, laboratory, and project teams, using risk-based and engineering-led approaches to improve controls.
- Lead the daily operation of the EHS Engineer team, set work priorities, allocate activities, coach team members, and monitor delivery against agreed site EHS objectives.
- Lead or support complex risk assessments involving chemical hazards, potent compounds, containment, occupational exposure, equipment, and process interfaces.
- Provide EHS input to capital projects, design reviews, management of change, commissioning, technology transfer, and new product or process introduction, and verify that agreed EHS actions are progressed.
- Provide business perspective and strategic and tactical direction to support the development of EHS initiatives for the EHS Long Range Plan.
- Maintain working knowledge of applicable Irish and European EHS legal requirements, relevant site licences and permits, and AbbVie EHS standards within assigned areas of responsibility.
- Triage operational EHS escalations, assess risk and urgency, coordinate the response, and escalate significant matters to the Site EHS Manager.
- Coordinate incident investigations, audit readiness, corrective actions, and EHS programmes, ensuring technically sound and sustainable solutions.
- Support a positive site safety culture through visible field engagement, coaching, consultation, and partnership with operational leaders and employees.
- Coordinate routine EHS performance information, action tracking, and technical updates for review by the Site EHS Manager and relevant site governance forums.
- Act as delegated operational backfill for the Site EHS Manager when formally assigned; this delegation does not transfer permanent ownership of site EHS strategy, regulatory accountability, environmental governance, process safety governance, or budget accountability.
- Collaborate with Environmental and Process Safety roles, which continue to report directly to the Site EHS Manager; the Site EHS Lead does not approve, direct, or own their programmes unless specifically delegated for a defined activity.
- Coordinate EHS Engineers day to day, ensure technical quality of assigned work, triage operational matters, deliver assigned programmes, and escalate matters to the Site EHS Manager in a timely manner.
- A relevant EHS qualification is advantageous.
- Experience with potent compounds, containment, or occupational exposure management is advantageous.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget